Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 3, 2006, Pages

  Pache, Gregor ^a   Schäfer, Christina ^b   Wiesemann, Sebastian ^a   Springer, Erik ^b   Liebau, Max ^a   Reinhardt, Hans Christian ^b   August, Christian ^b   Pavenstädt, Hermann ^b   Bek, Martin Johannes ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bone morphogenetic protein 2; Cytosolic free calcium concentration

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CALCIUM; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 33748434099     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00214.2004     Document Type: Article

References (56)

1. +-ATPase activity in an immortalized human proximal tubule cell line. J Immunol 170: 931-940, 2003.
2. 2-induced gene, regulates the cellular redox state of podocytes. FASEB J 17: 682-684, 2003.
3. Bek MJ, Zheng S, Xu J, Yamaguchi I, Asico LD, Sun XG, and Jose PA. Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 60: 890-899, 2001.
4. Chan GK, Miao D, Deckelbaum R, Bolivar I, Karaplis A, and Goltzman D. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology 144: 5511-5520, 2003.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Hoffken K, and Wolfl S. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126: 271-279, 2000.
7. Ducy P and Karsenty G. The family of bone morphogenetic proteins. Kidney Int 57: 2207-2214, 2000.
8. Fisher CE, Michael L, Barnett MW, and Davies JA. Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. Development 128: 4329-4338, 2001.
9. Ghosh Choudhury G, Kim YS, Simon M, Wozney J, Harris S, Ghosh-Choudhury N, Abboud HE, Ghosh Choundhury G, and Ghosh-Choundhury N. Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase. J Biol Chem 274: 10897-10902, 1999.
10. Gratacos E, Checa N, and Alberch J. Bone morphogenetic protein-2, but not bone morphogenetic protein-7, promotes dendritic growth and calbindin phenotype in cultured rat striatal neurons. Neuroscience 104: 783-790, 2001.
11. Greiber S, Muller B, Daemisch P, and Pavenstadt H. Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colony-stimulating factor. J Am Soc Nephrol 13: 86-95, 2002.
12. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, and Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 53: 654-663, 1998.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
14. Gupta IR, Macias-Silva M, Kim S, Zhou X, Piscione TD, Whiteside C, Wrana JL, and Rosenblum ND. BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis. J Cell Sci 113: 269-278, 2000.
15. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, and Yoneda T. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14: 545-555, 2003.
16. Hay E, Lemonnier J, Fromigue O, and Marie PJ. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276: 29028-29036, 2001.
17. Hollnagel A, Oehlmann V, Heymer J, Ruther U, and Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274: 19838-19845, 1999.
18. Jiang Z, Seo JY, Ha H, Lee EA, Kim YS, Han DC, Uh ST, Park CS, and Lee HB. Reactive oxygen species mediate TGF-β1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem Biophys Res Commun 309: 961-966, 2003.
19. Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, and Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7: 949-960, 2002.
20. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755-1766, 1994.
21. Kawabata M, Imamura T, and Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9: 49-61, 1998.
22. Kerjaschki D and Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 7: 2518-2526, 1996.
23. Kreider BL, Benezra R, Rovera G, and Kadesch T. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255: 1700-1702, 1992.
24. Lai CF and Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J Biol Chem 277: 15514-15522, 2002.
25. Lal MA, Brismar H, Eklof AC, and Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 61: 2006-2014, 2002.
26. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, and Janssen-Heininger YM. Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 283: C714-C721, 2002.
27. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, and Ryoo HM. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73: 114-125, 1999.
28. Li X, Ionescu AM, Schwarz EM, Zhang X, Drissi H, Puzas JE, Rosier RN, Zuscik MJ, and O'Keefe RJ. Smad6 is induced by BMP-2 and modulates chondrocyte differentiation. J Orthop Res 21: 908-913, 2003.
29. Locklin RM, Riggs BL, Hicok KC, Horton HF, Byrne MC, and Khosla S. Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J Bone Miner Res 16: 2192-2204, 2001.
30. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, and Karsenty G. BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev 9: 2808-2820, 1995.
31. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, and Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677, 1999.
32. Martinez G, Mishina Y, and Bertram JF. BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies. Int J Dev Biol 46: 525-533, 2002.
33. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, and Brady HR. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-β1. J Biol Chem 275: 9901-9904, 2000.
34. Miyazaki Y, Oshima K, Fogo A, and Ichikawa I. Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int 63: 835-844, 2003.
35. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W, and Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997.
36. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, and Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90: 3645-3649, 1993.
37. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, and Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338, 2002.
38. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905, 2000.
39. Ogata T, Wozney JM, Benezra R, and Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA 90: 9219-9222, 1993.
40. Palcy S and Goltzman D. Protein kinase signalling pathways involved in the upregulation of the rat α(I) collagen gene by transforming growth factor β1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem J 343: 21-27, 1999.
41. Reid MB and Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 171: 225-232, 2001.
42. Riser BL, Cortes P, Yee J, Sharba AK, Asano K, Rodriguez-Barbero A, and Narins RG. Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-β. J Am Soc Nephrol 9: 827-836, 1998.
43. Rudiger F, Greger R, Nitschke R, Henger A, Mundel P, and Pavenstadt H. Polycations induce calcium signaling in glomerular podocytes. Kidney Int 56: 1700-1709, 1999.
44. Ruzinova MB and Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410-418, 2003.
45. Sakurai D, Yamaguchi A, Tsuchiya N, Yamamoto K, and Tokunaga K. Expression of ID family genes in the synovia from patients with rheumatoid arthritis. Biochem Biophys Res Commun 284: 436-442, 2001.
46. Scheufler C, Sebald W, and Hulsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7. A resolution. J Mol Biol 287: 103-115, 1999.
47. Shah SV. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol Renal Fluid Electrolyte Physiol 254: F337-F344, 1988.
48. Shou J, Murray RC, Rim PC, and Calof AL. Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage. Development 127: 5403-5413, 2000.
49. Terkeltaub RA, Johnson K, Rohnow D, Goomer R, Burton D, and Deftos LJ. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells). J Bone Miner Res 13: 931-941, 1998.
50. Tournay O and Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 16: 2418-2430, 1996.
51. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, and Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91: 1160-1167, 2002.
52. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, and Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224, 1990.
53. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, and Hruska KA. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63: 2037-2049, 2003.
54. Wang S and Hirschberg R. BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 284: F1006-F1013, 2003.
55. Yoshikawa H, Takaoka K, Shimizu N, and Ono K. Solubility of a bone-inducing substance from a murine osteosarcoma. Clin Orthop 182: 231-235, 1984.
56. Zhao GQ. Consequences of knocking out BMP signaling in the mouse. Genesis 35: 43-56, 2003.